Drugs / RAZUPENEM
RAZUPENEM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00671580 | May 2008 → Feb 2009 | skin infection | Protez Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RAZUPENEM | ChEMBL registry synonym — accepted as the source's own label CHEMBL1256722 ↗ |
| Known as | PTZ-601 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1256722 ↗ |
| Known as | PZ-601 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00671580 ↗ |
| Known as | SM-216601 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1256722 ↗ |
| Known as | SMP-601 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1256722 ↗ |
| Modality | Small molecule | “novel investigational carbapenem antibiotic” NCT00671580 ↗ |
| Route | Intravenous | “Intravenous PZ-601” NCT00671580 ↗ |